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This study of patients with postpneumonectomy syndrome treated by mediastinal repositioning
reports short and long-term outcomes and quality of life assessment. Surgical repositioning of the
mediastinum can be performed with low mortality and morbidity and provides immediate and lasting
symptomatic relief to patients with postpneumonectomy syndrome.
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Secretory phospholipase A2 (sPLA2), an important mediator of inflammation in the gut, has also been
implicated in affecting cell proliferation through its byproducts. In this study we demonstrate the
importance of sPLA2 in early gastroduodenal reflux–induced mucosal hyperplasia.
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and T. R. DeMeester, MD, Los Angeles, Calif
Neoadjuvant therapy is commonly used before surgical resection for esophageal cancer, and the
esophagectomy is often done as a transhiatal procedure. Compared with a transhiatal resection, an en
bloc resection reduced the incidence of local recurrence and improved overall survival and survival in
patients with residual disease after neoadjuvant therapy.
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A unique bioengineered, microporous, drug-eluting graft had excellent patency throughout the 6
months after implantation. Biological agents, heparin and sirolimus, were impregnated into the graft
and encouraged luminal endothelialization and neointimal formation. This graft has the potential to
become an implantable graft for coronary artery bypass grafting.
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Magnetic resonance imaging demonstrated significant left atrial and ventricular reverse remodeling
and improvement of forward left ventricular ejection fraction late (3–4 years) after restrictive mitral
annuloplasty in patients with nonischemic dilated cardiomyopathy, mild to moderate heart failure,
and severe mitral regurgitation.
1254 The ‘‘occasional open heart surgeon’’ revisited
Joseph S. Carey, MD, Joseph P. Parker, PhD, Claude Brandeau, BS, and Zhongmin Li, PhD, Davis,
Calif
A high-volume surgeon becomes an ‘‘occasional open heart surgeon’’ when working at multiple
hospitals and performing a small volume of procedures at some of them. This study suggests that
volume is not as important as processes of care in determining outcomes of coronary artery bypass
grafting procedures and that system factors might be more important to outcomes than surgeon
experience.
1261 Long-term results of the open stent-grafting technique for extended aortic arch
disease
Kazuo Shimamura, MD, Toru Kuratani, MD, PhD, Goro Matsumiya, MD, PhD, Masaaki Kato, MD,
PhD, Yukitoshi Shirakawa, MD, PhD, Hiroshi Takano, MD, PhD, Noriyuki Ohta, MD, PhD, and
Yoshiki Sawa, MD, PhD, Osaka, Japan
Long-term observation showed safety and good durability of the open stent-graft technique for aortic
arch disease. This technique could be an attractive treatment option for aortic arch aneurysm with
distal extension and aortic dissection necessitating aortic arch replacement.
1270 Survival after valve replacement for aortic stenosis: Implications for decision
making
Tomislav Mihaljevic, MD, Edward R. Nowicki, MD, Jeevanantham Rajeswaran, MSc,
Eugene H. Blackstone, MD, Luigi Lagazzi, MD, James Thomas, MD, Bruce W. Lytle, MD,
and Delos M. Cosgrove, MD, Cleveland, Ohio
Current guidelines recommend aortic valve replacement for aortic stenosis when symptoms are
manifest. However, a complex interplay of factors, including severity of stenosis, left ventricular
hypertrophy and dysfunction, age, and prosthesis–patient size, influence late survival before
symptoms occur. Symptoms should not be the sole guideline for valve replacement.
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Fabio Patelli, MD, Giuseppe Minniti, MD, Mauro Masat, MD, Elena Cavarretta, MD,
and Carlo Valfre`, MD, Treviso, Italy
In 20-year experience, 608 consecutive patients underwent mitral valve repair with artificial
neochordae with the following outcomes: operative mortality less than 1%, freedoms from
reoperation and recurrent mitral regurgitation at 15 years of 92% and 85%, respectively, and repair
failures unrelated to rupture or degeneration of implanted GORE-TEX expanded
polytetrafluoroethylene sutures.
1288 Operative delay for peripheral malperfusion syndrome in acute type A aortic
dissection: A long-term analysis
Himanshu J. Patel, MD, David M. Williams, MD, Narasimham L. Dasika, MD,
Yoshikazu Suzuki, MD, and G. Michael Deeb, MD, Ann Arbor, Mich
This is a long-term analysis of a strategy of initial percutaneous fenestration and stenting with planned
delayed operative repair for patients presenting with acute type A aortic dissection, peripheral
malperfusion, and ischemic end-organ dysfunction.
1297 Impact of left atrial volume reduction concomitant with atrial fibrillation
surgery on left atrial geometry and mechanical function
Akira Marui, MD, PhD, Yoshiaki Saji, MD, Takeshi Nishina, MD, PhD, Eiji Tadamura, MD, PhD,
Shotaro Kanao, MD, Takeshi Shimamoto, MD, Nozomu Sasahashi, MD, Tadashi Ikeda, MD, PhD,
and Masashi Komeda, MD, PhD, Kyoto, Japan
LA volume reduction surgery concomitant with the Maze procedure was a predominant independent
variable that influenced postoperative left atrial geometry and mechanical function in patients with
refractory atrial fibrillation and left atrial enlargement. Left atrial reduction helped restore booster
pump and reservoir function, and facilitated left atrial reverse remodeling.
1306 Effect of procedural volume on outcome of coronary artery bypass graft surgery
in Japan: Implication toward public reporting and minimal volume
standards-
Hiroaki Miyata, MD, Noboru Motomura, PhD, MD, Yuichi Ueda, PhD, MD, Hikaru Matsuda, PhD,
MD, and Shinichi Takamoto, PhD, MD, Tokyo and Hyogo, Japan
In Japan, high-volume compared with low-volume providers of CABG had better outcomes. For
public reporting, hospital-based evaluation might be more credible than surgeon-based evaluation.
Although minimal volume standards might be effective to improve quality to some extent, volume
has limitations as a marker of quality because of its wide range of variance.
Surgery for Congenital
Heart Disease (CHD)
1313 Surgical treatment of congenital mitral valve disease: Midterm results of
a repair-oriented policy
Guido Oppido, MD, Ben Davies, MRCS(Eng), D. Michael McMullan, MD, Andrew D. Cochrane,
MD, FRACS(CTh), Michael M. H. Cheung, MD, Yves d’Udekem, MD, PhD, and Christian
P. Brizard, MD, Melbourne, Australia
Despite a wide spectrum of valve morphology, associated lesions, and small patient size, successful
repair for congenital mitral disease can be performed with low mortality and acceptable reoperation
rate while obviating risks associated with valvular prostheses. Suboptimal repair was a predictor for
reintervention; however, further repair was often successful.
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1322 Short-term conversion to open surgery after endovascular stent-grafting of the
thoracic aorta: The Talent thoracic registry
Marek P. Ehrlich, MD, Christoph A. Nienaber, MD, Herve´ Rousseau, MD, Jean-Paul Beregi, MD,
Philippe Piquet, MD, Marc Schepens, MD, Jean-Michelle Bartoli, MD, Martin Schillinger, MD, and
Rossella Fattori, MD, Vienna, Austria, Rostock, Germany, Toulouse, Lille, and Marseille, France,
Nieuwagein, The Netherlands, and Bologna, Italy
Endovascular treatment for thoracic aortic disease with the Talent stent-graft is associated with
a relatively low rate of late conversion to conventional surgery. Better results may be achieved by
excluding patients with Marfan syndrome for such a procedure and early aggressive treatment for
early type I endoleaks.
1327 Endocardial hypothermia and pulmonary vein isolation with epicardial
cryoablation in a porcine beating-heart model
Saqib Masroor, MD, MHS, Mary-Ellen Jahnke, RN, Antoine Carlisle, DVM, Catherine Cartier, BSc,
MEng, Jean-Pierre LaLonde, BSME, Timothy MacNeil, BS, Andre Tremblay, BSME, and Fred Clubb
Jr, DVM, PhD, Hackensack, NJ, Kirkland, Quebec, Canada, and College Station, Tex
The degree of endocardial hypothermia is inversely related to the thickness of the tissues. In a porcine
model of normothermic beating-heart epicardial cryoablation, acute and long-term pulmonary vein
isolation and histologic transmurality were demonstrated. Endocardial temperatures during the
procedure were sufficiently low for cell killing.
1334 Stereoscopic vision display technology in real-time three-dimensional
echocardiography-guided intracardiac beating-heart surgery
Nikolay V. Vasilyev, MD, Paul M. Novotny, PhD, Joseph F. Martinez, DVM, Hugo Loyola, MS,
Ivan S. Salgo, MD, MS, Robert D. Howe, PhD, and Pedro J. del Nido, MD, Boston, Cambridge, and
Andover, Mass
Stereoscopic vision display was evaluated as an aid for intracardiac navigation during 3-dimensional
echocardiography-guided beating-heart surgery in a model of atrial septal defect closure. The study
demonstrates that stereoscopic vision technology has significant advantages over the conventional
display when used to guide beating-heart intracardiac surgical intervention, potentially improving
procedure safety.
1342 Low-dose dobutamine cardiac magnetic resonance imaging with myocardial
strain analysis predicts myocardial recoverability after coronary artery bypass
grafting
D. Dean Potter, MD, Philip A. Araoz, MD, Kiaran P. McGee, PhD, W. Scott Harmsen, MS,
Jayawant N. Mandrekar, PhD, and Thoralf M. Sundt III, MD, Rochester, Minn
Dobutamine-stressed tissue-tagged magnetic resonance imaging with strain analysis was used to
predict myocardial recoverability after coronary artery bypass. Strain analysis was able to quantitate
changes with dobutamine stress and after bypass grafting. Magnetic resonance strain analysis
predicted recoverability of myocardium after surgical intervention and holds promise as
a preoperative assessment tool.
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Jiann-Shing Shieh, PhD, Tzu-Yu Lin, MD, and Shu-Hsun Chu, MD, Taipei, Taiwan,
Republic of China
In this prospective randomized double-blind study, the combination of infusion of 0.15% bupivacaine
in the thoracotomy wound and intravenous patient-controlled analgesia reduced both acute pain (day
1 to day 3) and chronic pain (3 months) in minimally invasive cardiac surgery when compared with
patient-controlled analgesia alone.
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1353 Improving outcomes with long-term ‘‘destination’’ therapy using left
ventricular assist devices
James W. Long, MD, PhD, Aaron H. Healy, BS, Brad Y. Rasmusson, MD, Cris G. Cowley, MD,
Karl E. Nelson, RN, MBA, Abdallah G. Kfoury, MD, Stephen E. Clayson, MD, Bruce B. Reid, MD,
Stephanie A. Moore, MD, Douglas U. Blank, MD, and Dale G. Renlund, MD, Salt Lake City,
Utah, Boston, Mass, and Idaho Falls, Idaho
Destination therapy experience using long-term left ventricular assist devices was analyzed relative
to the benchmark REMATCH trial to evaluate the potential for improving outcomes with this
pioneering therapy for advanced heart failure. This analysis provides evidence that destination
therapy can be improved well beyond the experience of the REMATCH trial.
1362 Extracorporeal lung membrane provides better lung protection than
conventional treatment for severe postpneumonectomy noncardiogenic acute
respiratory distress syndrome
Manuela Iglesias, MD, Philipp Jungebluth, Carole Petit, RN, Marı´a Purificacio´n Matute, MD,
Irene Rovira, MD, Elisabeth Martı´nez, MD, Miguel Catalan, MD, Jose´ Ramirez, MD,
and Paolo Macchiarini, MD, PhD, Barcelona, Spain
A pig model of severe postpneumonectomy noncardiogenic ARDS was developed by performing
a left pneumonectomy and depleting the surfactant of the right lung. The combination of a pumpless
extracorporeal lung membrane and static ventilation significantly reduced pulmonary morbidity of
the injured lung and yielded better survival than conventional treatment.
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1372 Association of device surface and biomaterials with immunologic sensitization
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Isaac George, MD, Patrick Colley, BS, Mark J. Russo, MD, Timothy P. Martens, MD,
Elizabeth Burke, MS, Mehmet C. Oz, MD, Mario C. Deng, MD, Donna M. Mancini, MD,
and Yoshifumi Naka, MD, PhD, New York, NY
We investigated the hypothesis that axial-flow devices (n 5 16) without biologic membranes would
cause less allosensitization than devices (n5 36) with biologic membranes. Overall, fewer axial-flow
than pulsatile devices demonstrated positive anti-HLA antibody during support, and fewer
posttransplant episodes of acute rejection per patient were seen.
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Alexander Sasha Krupnick, MD, Andrew E. Gelman, PhD, Mikio Okazaki, MD, PhD, Jiaming Lai,
MD, Nitin Das, MD, Seiichiro Sugimoto, MD, Thomas H. Tung, MD, Steven B. Richardson, BS,
G. Alexander Patterson, MD, and Daniel Kreisel, MD, PhD, St Louis, Mo
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